ecrin-mdr-crcClinical2017Metastatic colorectal cancer patientsMetastatic Colorectal Cancer PatientsInterventionalhttps://newmdr.ecrin.org/Study/20951Netherlands10ECRIN MDRRecruitingfalseThe use of a medical nutrition supplement in patients with metastatic colorectal cancerInterventions: The test group will be asked to take the medical nutrition supplement twice per day, during the first 3 cycles of CAPOX-B treatment. The control group receives the same medical treatment with CAPOX-B and standard of care. Primary outcome(s): To explore the compliance to nutritional test product intake Study Design: Randomized controlled trial, Open (masking not used), N/A , unknown, Parallel2017-10-1520951NL6567